P/B
3,2
Zevra Therapeutics
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
$703.1M
Market Cap • 9/17/2026
2006
(20 years)
Founded
2015
(11 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
5,2
P/EBITDA
8,5
P/OCF
—
P/FCF
—
P/E
12,9
BVPS
3,7
EPS
0,9
Market Cap
Market Cap
703,1M
EV
483M
EV/Revenue
3,5
EV/EBITDA
5,8
EV/EBIT
5,9
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-375,4M
Profitability
Gross Margin
97,7%
EBITDA Margin
61%
EBIT Margin
60,5%
Net Margin
42,8%
D&A/EBITDA
0,8%
R&D/Revenue
4,4%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
39,3%
% PPE
0,8%
% Goodwill
1,6%
ROE
34,5%
ROIC
231,5%
Growth
CAGR Revenue 5Y
36,8%
CAGR Op. Income 5Y
58%
CAGR OCF 5Y
-100%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
5,2
Quick Ratio
5
Interest Coverage
1442,8%
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!